Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
7/11/2025
BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
7/11/2025
China's NHSA Unveils 2025 Drug Directory Revisions and Submission Guid...
7/11/2025
China Issues 2nd Batch of Rare Disease Clinical Guidelines to Strength...
7/10/2025
Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...
7/10/2025
China Approves Three New Drugs for Cancer, ED and Pediatric Sleep Diso...
7/10/2025
Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery...
7/10/2025
China's Biopharma Licensing Deals Surge in H1 2025, Fueled by Cross-Bo...
7/9/2025
Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...
7/9/2025
China Struggles to Maintain Grip on India's Bulk Drug Market Amid Risi...
7/9/2025
Hansoh Pharma Launches Phase 1 Trial of HS-20093 with Adebrelimab in F...
7/9/2025
NKCellTech Secures Nearly CNY100M in Series A+++ Financing
More>>
Feature Articles
7/10/2025
China's Rising Biotechnology Sector: Friend or Foe? (EGGI)
7/8/2025
As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...
7/2/2025
FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...
7/2/2025
Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)
7/1/2025
Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...
7/1/2025
BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...
7/1/2025
China Launches Landmark Measures to Boost Innovative Drug Industry, Se...
6/27/2025
Analyzing Key Trends in China's Patent-Linkage System and Their Impact...
6/27/2025
Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...
6/25/2025
Breaking the Boundaries: A New Map of Physician Behavior in China's Di...
6/19/2025
Structuring Cross Border China Biotech 'NewCo' Transactions (Life Scie...
More>>
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit